|
|
Volumn 3, Issue , 1998, Pages 39-54
|
|
The therapeutic applications of cannabinoid agonists and antagonists
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE;
4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL;
4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE;
ADENYLATE CYCLASE;
ANANDAMIDE;
CALCIUM CHANNEL;
CANNABINOID;
CANNABINOID RECEPTOR;
CANNABINOID RECEPTOR AGONIST;
CANNABINOID RECEPTOR ANTAGONIST;
CANNABIS;
DRONABINOL;
IBUPROFEN;
N (4 HYDROXYPHENYL)ARACHIDONYLETHANOLAMIDE;
N [ENDO 1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL] 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL)PYRAZOLE 3 CARBOXAMIDE;
PARTIAL AGONIST;
RECEPTOR SUBTYPE;
RIMONABANT;
UNCLASSIFIED DRUG;
ANALGESIA;
APPETITE;
COGNITION;
HUMAN;
IMMUNITY;
INFLAMMATION;
INTRAOCULAR PRESSURE;
LOCOMOTION;
MEMORY;
REVIEW;
SMOOTH MUSCLE CONTRACTION;
UTERUS CONTRACTION;
VOMITING;
|
|
EID: 0031958362
PISSN: 13619195
EISSN: None
Source Type: Journal
DOI: 10.1517/14728214.3.1.39 Document Type: Review |
|
Times cited : (5)
|
|
References (59)
|
